Bank of Nova Scotia’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,974
Closed -$2.56M 1084
2023
Q2
$2.56M Buy
+8,974
New +$2.49M 0.01% 480
2022
Q1
Sell
-41,502
Closed -$7.41M 1341
2021
Q4
$7.41M Buy
+41,502
New +$8.19M 0.01% 611

Other funds holding SWAV

Bank of Nova Scotia's SWAV Position: Q3 2023 in Review

Bank of Nova Scotia sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2023, closing a stake of 8,974 shares — an estimated $2.56M sold.

Bank of Nova Scotia first reported a position in SWAV in Q4 2021 and held it in 2 quarters. The position peaked at $7.41M in Q4 2021. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

  • Bank of Nova Scotia reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Bank of Nova Scotia sold 8,974 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $2.56M.
  • Bank of Nova Scotia first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Bank of Nova Scotia's Shockwave Medical, Inc. Common Stock position peaked at $7.41M in Q4 2021.
  • 412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on Bank of Nova Scotia's 13F filing for Q3 2023, filed 14 Nov 2023.